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Investigation of the Potential for Binding of Di(2.ethylhexyl) Phthalate (DEHP) and Di(2-
ethylhexyl) Adipate (DEHA) to Liver DNA in Vivo. VON DÄNIKEN, A., LUTZ, W. K., JÄCKH, 
R., AND ScHLATTER, C. (1984). Toxico/. App/. Pharmaco/. 73, 373-387. It was the aim oftbis 
investigation to determine whether covalent binding of di(2.ethylhexyl) phthalate (DEHP) to rat 
liver DNA and of di(2-ethylhexyl) a(iipate (DEHA) to mouse liver DNA could be a mechanism 
of action contributing to the observed induction of liver tumors after lifetime feeding of the 
respective rodent species with high doses of DEHP and DEHA. For this purpose, DEHP and 
DEHA radiolabeled in different parts of the molecule were administered orally to female rats 
and mice, respectively, with or witbout pretreatment for 4 weeks with 1% unlabeled compound 
in the diet. Liver DNA was isolated after 16 hr and analyzed for radioactivity. The data were 
converted to a covalent binding index, CBI = (micromoles of substance bound per mole of DNA 
nucleotides)/(millimoles of substance applied per kilogram body weight), in order to allow a 
quantitative comparison also with other carcinogens and noncarcinogens. Administration of 
[ 14qcarboxylate-labeled DEHP to rats resulted in no measurable DNA radioactivity. The Iimit 
of detection, CBI < 0.02 was about 100 times below the CBI of compounds where an observable 
tumor-inducing potential could be due to genotoxicity. With [14C]- and [3H]DEHP Iabeted in 
the alcohol moiety, radioactivity was clearly measurable in rat liver DNA. HPLC analysis of 
enzyme-degraded or acid-hydrolyzed DNA revealed that the natural nucleosides or purine bases 
were radiolabeled whereas no radioactivity was detectable in those fractions where tbe carcinogen-
modified nucleoside or base adducts are expected. The respective Iimits of detection were at 0.07 
and 0.04 CBI units for the 1~ and 3H Iabels, respectively. The experiments with [14C)- and 
[lH]DEHA, labeled in the alcobol moiety and administered to mice, revealed aminute radioactivity 
of <50 dpm/mg liver DNA, too little to allow a nucleoside analysis to determine that fraction 
of the radioactivity which bad been incorporated via biosynthesis. Expressed in the CBI units, 
values of 0.05 to 0.15 for 14C and 0.01 to 0.12 for 3H resulted. Determination of the Ievel· of 
14C02 expiration revealed a linear correlation with the speciftc activity of DNA. Experiments 
with 2-ethyl[ 1·14C]hexanol perfonned with both rats and mice allowed the conclusion tbat most 
if not all DEHA radioactivity in mouse liver DNA was due to biosynthetic incorporation. 
A maximum possible true DNA binding by DEHA must be below CBI 0.01. Pretreatment of 
the animals witb unlabeled compound bad no effect on the DNA radioactivities in either species. 
The present negative data, in conjunction witb other negative short-term tests for mutagenicity, 
strongly indicate that covalent interaction with DNA is highly unlikely to be the mode of tu-
morigenic action of DEHP and DEHA in rodents. 
The plasticizer di(2-ethylhexyl) phthalate 
(DEHP) was reported to induce liver tumors 
in F344 rats and B6C3Fl mice in a 2-year 
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feeding experiment (National Toxicology 
Program, 1982a). The doses used (12,000 and 
6000 ppm DEHP in the diet for the rats and 
6000 and 3000 ppm for the mice) caused in-
creased incidences of hepatocellular carci-
noma or neoplastic nodules in female rats of 
either dose group and in male rats of the high er 
dose group as well as hepatocellular carcinoma 
and adenoma in mice of either sex and dose 
group. 
Di(2-ethylhexyl) adipate (DEHA) was re-
ported to induce liver tumors in mice in a 2-
year feeding experiment with 12,000 ppm and 
25,000 ppm DEHA admixed to the diet (Na-
tional Toxicology Program, 1982b). Increased 
incidences of hepatocellular adenoma and 
carcinoma in males and females were found 
in either dose group. In rats, no difference in 
incidence or type of tumors between treated 
and control animals was observed after a 2-
year feeding with 12,000 or 25,000 ppm 
DEHA in the diet. 
Considering the widespread use of DEHP 
and DEHA and the possible exposure of the 
generat population to low doses, it seems im-
portant to determine whether the tumor·in-
ducing potential of these compounds is based 
upon a genotoxic mode of action via DNA 
binding or whether other mechanisms are re-
sponsible. The answer is essential for any ex .. 
trapolation between species and from high to 
low doses. 
DEHP and DEHA are inducers of peroxi-
somes in rats (Moody and Reddy, 1978; 
Reddy, 1981; Mangham et al., 1981; Gray et 
al., 1982). The peroxisome inducers may form 
a novel class of carcinogens (Reddy et al., 
1980). On the other band, data on a putative 
interaction of radiolabeled DEHP with rat 
liver DNA in vivo have been presented by 
Albro et a/. ( 1982). In a subsequent report 
(Albro et al., 1983) which inch.ided data on 
dual Iabel experiments, this group presented 
indirect evidence that the association of ra-
diolabel with DNA might have been due to 
biosynthetic incorporation. The main limiting 
factor in their studies was the fact that the low 
Ievel ofDNA radioactivity allowed no analysis 
of the DNA constituents to distinguish be-
tween biosynthetic incorporation of the ra· 
diolabel and true covalent deoxyribonucleo-
tide-DEHP adducts. 
These preliminary findings prompted us to 
perform a DNA-binding assay with DEHP in 
rat and mouse Ii ver and :pEHA in mause Ii ver. 
Large amounts of radioactivity were admin-
istered in our study in order to achieve suf-
ficiently high specific activities in the DNA to 
allow for an analysis of the source of the ra-
diolabel and to irnprove the Iimit of detection 
in case of a negative result. The present study 
was carried out with DEHP and DEHA ra-
dioactively labeled in three different positions 
as illustrated in Fig. 1. A 14C Iabel was intro-
duced either at the carboxylate carbon atom 
of the phthalate moiety (I) or at C -1 of the 
alcohol moiety of DEHP (II) and of DEHA 
(V). [3H]DEHP II and [3H]DEHA VI were 
tritiated in positions 2 and 3 of the alcohol 
moiety. In order to investigate whether 2-
ethylhexanol (EH), a known rnetabolite of 
DEHP and DEHA, can interact with DNA, 
[1-14C]EH IV was also studied. 
The long-term exposure to DEHP and 
DEHA used in the carcinogenicity studies 
could have induced qualitative and/or quan-
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FIG. 1. Structures of radiolabeled test compounds used. 
(1, II, 111) Di(2-ethylhexyl) phthalate; (IV) 2-ethylhexanol; 
(V, VI) di(2-ethylhexyl) adipate. • = 1"C, T = 3H. 
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titative changes in the enzymatic drug me-
tabolism pattem. In order to investigate 
whether such pretreatment could have an ef-
fect on DNA binding, groups of animals were 
pretreated for 4 weeks with a diet containing 
10 gjkg DEHP or DEHA. 
METHODS 
Chemieals and :radiolabeled compounds. All enzymes 
were obtained from Sigma Chemical Company, St. Louis, 
Missouri. DEHP, 14C-labeled in the carboxylate carbon 
(Fig. 1, compound I) was synthesized at I CI, Macclesfield, 
UK, with a specific activity of 46.8 mCi/mmol. DEHP 
and DEHA Iabeted with 14C and 3H in the alcohol moiety 
(II, lß, V, and VI) were synthesized at BASF AG, Lud-
wigshafen, FRG, with specific activities of 39.5, 132.8, 
38.9, and 124.7 mCi/mmol, respeclively. The [14C]EH IV 
was produced at BASF with a specific activity of 34.4 
mCi/mmol. The radiochemical purity was checked 1 day 
before use by thin-layer chromatography on silica-gel plates 
with methylene chloride for DEHA and DEHP and meth-
ylene chloride:methanol 1: 1 for EH. The radiochemical 
purity was 97.8% for [3H]DEHA and >99% for the other 
compounds. Unlabeled DEHP was obtained from Fluka 
AG, Buchs, Switzerland. The compounds were dissolved 
in olive oil (Konsum Verein, Zurich, Switzerland). One 
milliliter ofthe application solution of [14C]DEHP I con-
tained 136 mg DEHP with 2.54 mCi. Compounds ß and 
m were administered tagether to rats as a solution of 129 
mg DEHP/ml with 1.12 mCi{ml of[ 14C]DEHP and 9.86 
mCi/ml of [3H]DEHP. Compounds V and VI were ad-
ministered tagether to mice as a solution of 119 mg DEHA/ 
ml with 3.85 mCi/ml of[14C]DEHA and 27.7 mCi{ml of 
[lH]DEHA. The 14C to 3H ratio was chosen to be about 
l :8 because of different counting efficiencies and the 14C 
spillover in the 3H channel which reduces the accuracy 
of the determination of 3H counts. [I"C]DEHP II was 
administered to mice as a solution of 26.4 mg DEHP/ml 
olive oll witb 2.67 mCi/ml of 14C Iabel. EH IV was used 
undiluted. One milliliter of the application solution con-
tained 12.0 and 11.0 mg EH with 3.15 and 2.91 mCi 14C 
for the treatment of rats and mice, respectively. 
Animals and treatments. Fernalerats ofthe Fischer 344 
strain and female mice ofthe NMRI strain, 150-200 and 
21-23 g body wt, respectively, were supplied by Charles 
River Wiga, Sulzfeld, FRG. They were held in Macrolone 
cages in groups of four animals and were marked by tail 
painting. Room temperature of 21 ± 2°C and humidity 
of 55 ± 15% were registered continuously. The illumination 
time was 12 hr per day. The animals were fed with diet 
No. 343 purchased from Kliba Klingentalermühle, Kai-
seraugst, Switzerland (Batch Nos. 55/81 and 59/82). 
Analysis of contaminants of feed was perfonned by RCC, 
Itingen, Switzerland, and conformed to EPA specifications 
of maximally tolerable Ievels. The pretreated groups were 
fed a diet containing 10 g/kg DEHP and DEHA, respec-
tively, prepared and analyzed with respect to concentration, 
stability, and homogenity by BASF. Feed and water were 
given ad /ibitum. Feed consumption was measured daily. 
The body weight was monitored weekly. 
After 2 to 3 weeks of acclimatization, one group of 
animals was given the DEHP- or DEHA-containing diet 
for 4 weeks while the others received the regu1ar chow. 
The radiolabeled test compounds were then administered 
by oral gavage of the solutions described above on dose 
Ievels indicated in the tables. For each experiment two 
animals served as unlabeled controls and were treated 
with no radioactivity at all. 
Pharmacokinetics. After the administration of the ra-
diolabeled compounds, the animals were held in all-glass 
metabolism cages, and urine was collected. An air stream 
of 0.4 Iiterimin transported the expired air to a trap with 
ethanolamine:methanol 1 :4 to collect the 14C02 expired. 
The production oftritiated water, HTO, from [3H]DEHP 
was determined on the basis of the specific activity of the 
HTO in the urine after dilution with water and repeated 
recondensation. 
Isolation of DNA. Sixteen hours after the administration 
of the radiolabeled compounds, the animals were killed 
by open heart puncture under ether anesthesia, and livers 
were excised and weighed. A crude chromatin fraction 
was prepared in the cold by a slightly modified method 
described by Yaneva and Dessev (1976): The liver was 
homogenized in 75 mM NaCl, 10 mM EDTA, 10 mM 
Tris/HO, pH 7.8, in a Potter-Elvehjem homogenizer. 
Nonidet P-40 detergent was added to a concentration of 
0.2%. After 15 min, the samples-were centrifuged for 5 
min at 700g. The crude chromatin pellet was washed once 
with 10 mM EDT A, I 0 mM Tris/HO, pH 7 .8. The isolation 
and purification of DNA from chromatin at room tem-
perature followed the standard method used in our lab-
oratory, which is based on a method of two extractions 
with phenol:chloroform:isoamyl alcohol 25:24:1 and a 
hydroxylapatite column chromatography as the main pu-
rification step (Markov and lvanov, 1974). After dialysis 
against water at 4 °C o~ernight, addition of Naa t~ a 
concentration of 0.2 M and precipitation after addition 
of a twofold volume of ethanol, the DNA was dried on 
an aspirator vacuum and dissolved in 4 or 5 ml of I 0 
mM Tris/HO, 10 mM MgCh, pH 7.0. In the experiment 
with mice the ethanol precipitation step was repeated once. 
The DNA content was determined on the basis of a uv 
absorbance of 20 at 260 nm for a solution of l mg/ml. 
An aliquot of 1 ml was used for radioactivity counting. 
If no radioactivity was measurable, the remaining DNA 
solution was added to the vial and counted again. If ra-
dioactivity was detectabJe on a Ievel of at least 50 cpm/ 
mg, DNA was degraded enzymatically or depurinated with 
hydrochloric acid, and the deoxyribonucleosides or purine 
bases were separated by HPLC to determine biosynthetic 
incorporation of radioactivity into the DNA. 
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Determination of covalent binding indices (CBI). The 
specific radioactivity of DNA was normalized by the dose 
administered: 
CBI' = dpmfmg DNA 
dpm/kg body wt 
This value was converted to the molar units, 
CBI = #LMOl chemical bound/mol DNA nucleotide 
mmol chemical applied/kg body wt ' 
according to CBI = CBI' X 309 X 1 (f on the basis of an 
average molecular weight of 309 gfmol DNA nucleotides 
(Lutz, 1979). 
Analysis of deoxyribonucleosides. DNA was degraded 
enzymatically to deoxyribonucleosides by a method slightly 
modifted from King et a/. ( 1977): 1-2 mg ofDNA dissolved 
in 1 ml 10 mM Tris/HO, 10 mM MgCh, pH 7.0, was 
incubated for 16 hr at 37°C with 250 units of deoxyri-
bonuclease I (EC 3.1.21.1) from bovine pancreas. Two 
hundred fifty microliters with 0.075 unit venom phos-
phodiesterase I (EC 3.1.4.1) and 2.5 units of alkaline phos-
phatase lU (EC 3.1.3.1) from Escherichia coli in a solution 
of SO mM Tris/HO, pH 9.0, were added and incubated 
for 24 hr at 37°C. Afterfiltration through 0.22-~tm filters 
(Millipore, Bedford, Mass.), the samples were loaded onto 
a HPLC reverse-pbase column (LiCbrosorb RP 18, 8 X 250 
mm, Knauer, Oberursel, FRG) and eluted with a flow of 
3.5 ml/min for 56 min with a methanol:water gradient 
0-10% for the first 5 min, 10-100% from 10 to 50 min. 
The optical density at 254 nm of the eluate was contin-
uously recorded in a ßow photometer (Perkin-Elmer 
LC55). Fractions of 7 ml were collected (unless indicated 
otherwise in fig. 7) and added to 10 mi Insta-Gel (Packard) 
for radioactivity counting. 
The background radioactivity in the 14C channel was 
determined for each chromatogram on the basis of mean 
and standard deviation of fractions 1 and 11-28. The 
background radioactivity in the 3H channel is not constant 
over the entire chromatogram due to the quenching by 
a higher methanol content in the later fractions. The back-
ground radioactivity of the first 12 fractions and the re-
spective standard deviation were therefore detennined with 
linear regression of the cpm values of fractions 1, 3, 4, 8, 
9, 11, and 12. The background radioactivity of fractions 
J 3-28 was detennined on the basis ofthe mean and stan-
dard deviation of these single fractions obtained from 
control DNA. 
Analysis of purine bases. The DNA was depurinated 
by acid hydrolysis. HO ( 1 M) was added to the DNA 
solution to give a concentration of 0.1 M. The samples 
were incubated for 1 hr at 70°C (Meier-Bratschi et a/., 
1983). After the samples were fittered through 0.22-pm 
filters, they were loaded onto an HPLC reverse-phase col-
umn, ~ndapack C18 (7.8 X 300 mm, Waters), and eluted 
with 3.5 ml/min 0.01 M ammonium phosphate, pH 4, 
with 1% methanol. The elution was monitared at 254 
nm. Two-minute fractions of 7 ml were collected and 
added to 10 mllnsta-Gel for radioactivity counting. 
The background radioactivity in the 14C and 3H channels 
was determined for each chromatogram on the basis of 
the mean and standard deviation of fractions l, 4, 5, 7, 
8, and 10-27. 
Seinti/laiion counting: Statistics. The radioactivity 
counting was carried out in a liquid scintillation counter, 
Tri-Carb 460 CD (Packard), with Insta-Gel (Packard) as 
the scintillation mixture. For small amounts of radioac-
tivity, the samples were counted 4 X 40 min. The back-
ground was determined as the mean count of two DNA 
samples isolated tagether with the test samples from an-
imals which bad not received radiolabels but which were 
held tagether with the test animals. These values, given 
in the tables and figures, varied between the experiments 
with standard deviations of ± 1.1 cpm and ±0.8 cpm in 
the 14(: and 3H channels, respectively (statistical mean of 
standard deviations within each pair ofbackground counts) 
(Kaiser, 1965). This standard deviation was also used to 
decide whether significant radioactivity was detected in 
the vial containing DNA oftreated animals. The counting 
efficiencies varied with the quench grade of the samples 
and were determined with intemal standards. They are 
given in footnotes to the tables. 
RESULTS 
General Observations and Pharmacokinetic 
Parameters 
In the rat. Feed consumption did not differ 
between the pretreated and the nonpretreated 
rats. The daily feed intake in the respective 
groups was 12.2 ± 1.2 and 13.8 ± 2.1 g per 
rat, resulting in a DEHP dose for the pretreated 
rats of 0.65 ± 0.05 gfkg body wt per day. No 
deviation from the normal body weight gain 
known for this strain was observed. 
The pretreatment of rats with DEHP in the 
feed (10 g/kg) for 4 weeks increased the liver 
weight to body weight ratio significantly, a 
finding which is in accordance with other re-
ports (Carpenter et al., 1953; Harris et a/., 
1956; Moody and Reddy, 1978). It was 56.2 
± 2.4 g/kg body wt compared to 41.3 ± 3.9 
g/kg body wt of the nonpretreated rats. The 
liver enlargement resulted in a more rapid 
metabolism of the subsequent dose of radio-
labeled DEHP as is illustrated by the more 
rapid and more extensive exhalation of 14C02 
generated by the degradation of 14C-labeled 
DEHP I and II (see below). 
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2 4 8 16 
Time (hours) 
FIG. 2. Cumulative exhalation of •.tco2 after oral ad-
ministration of [I'X:]DEHP I to DEHP-pretreated ( •) and 
nonpretreated (A) rats. Means of two animals. 
About one-third of the radioactive dose of 
all four compounds was excreted within 16 
hr in the urine. By taking into account the 
additional metabolites still present in the body, 
it is reasonable to assume that at least half 
the dose had been absorbed from the gas-
trointestinal tract and passed the liver. 
Exhalation of 14C02 by the rats treated with 
the carboxylate-Iabeled DEHP I accumulated 
within 16 hr to less than a fraction of 3 X 1 o-s 
ofthe radioactivity administered (Fig. 2). This 
finding is so small tbat it does not have to be 
the result of a metabolic cleavage of the car-
boxylate carbon of DEHP I from its benzene 
moiety, but could be due to radiolabeled im-
purities. The 14C02 exhalation after admin-
istration of a/coho/-Iabeled DEHP ß is, how-
ever, in the order ofa few percent ofthe dose 
(Fig. 3). DEHP pretreatment resulted in an 
increased production of t4C02 • After admin-
istration of l-t4C-labeled 2-ethylhexanol IV, 
the fraction of expired 14C02 represented as 
much as 15% (Fig. 4). 
In the mouse. Feed consumption was 
slightly but not significantly increased in 
DEHA-pretreated mice. The daily feed intake 
in the respective groups was 7.12 ± 1.75 and 
5.44 ± 0.84 g per mouse, resuJting in a DEHA 
dose for the pretreated mice of 2.09 ± 0.57 
g/kg body wt per day. No deviation from the 
2 4 Time (hours) 
FIG. 3. Cumulative exhalation of 14C02 after oral ad· 
ministration of p4qDEHP D to DEHP-pretreated ( •) and 
nonpretreated (A) rats. Means of two animals. 
normal body weight gain known for this strain 
was observed. 
The DEHA radioactivity excreted in the 
urine within 16 hr was 60 ± 29 and 57 ± 28% 
of the 14C and 3H doses administered. By tak-
ing into account the additional metabolites 
still present in the body, it is reasonable to 
assume that most ofthe radiolabeled dose had 
been absorbed from the gastrointestinal tract 
and bad passed the liver. 
Production of tritiated water (HTO) from 
2 4 Time (hours) 16 
FIG. 4. Cumulative exhalation of 14C02 after oral ad-
ministration of P4CJEH IV to DEHP-pretreated rats. 
Means of two animals. 
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[lH]DEHA was determined on the basis of 
the specific activity ofHTO in the urine, which 
was between 1 and 4 X 107 dpm/ml. Under 
the assumption that HTO is distributed ho-
mogeneously in the body fluid and that the 
total water content of a mouse is 60% of its 
body weight, 3 and 1.5% ofthe dosebad been 
released as HTO in pretreated and nonpre-
treated animals, respectively. 
The 14C02 exhalation after administration 
of 14C-labeled DEHA, DEHP, and EH was in 
the order ofa few percent ofthe dose. DEHA 
pretreatment resulted in an increased pro-
duction of 14C02. The exhalation of 14C02 
after administration of P4C]EH was more 
rapid than that of DEHA and was more ex-
tensive (Fig. 5). 
The pretreatment of mice with DEHA in 
the food ( 10 g/kg) for 4 weeks increased the 
liver weight to body weight ratio slightly but 
not significantly. It was 78 ± 24 g/kg body wt 
as compared to 61 ± 14 g/kg body wt of the 
nonpretreated mice. The more rapid metab-
olism of the radiolabeled DEHA, illustrated 
by an increased exhalation of 14C02 , a more 
rapid excretion of radiotabei in the urine, and 
an increased HTO production, is probably due 
to this liver enlargement. 
---------, 
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2 4 Time (hours) 16 
FIG. 5. Cumulative exhalation of 14C02 after oral ad-
ministration of[14C]DEHA I to DEHA-pretreated (•) and 
nonpretreated (.._) mic:e, of [14C]EH IV (e) to DEHA-
pretreated mice, and of[1"C)DEHP m <•> to nonpretreated 
mice (dashed lines). Means oftwo animals. 
DNA-Binding Studies in the Rat 
The data on the radioactivity determined 
in the DNA are summarized in Table 1. With 
carboxylate-labeled DEHP I, minute radio-
activity could be detected in only one of four 
DNA samples. In all other samples, irrespec-
tive of the DEHP pretreatment, the radioac-
tivity was below the. Iimit of detection of the 
order of 0.02 CBI unit. In one case, a small 
amount of radioactivity was detected in the 
DNA. lt is very unlikely that this radioactivity 
originated from a radioactive labeled DNA-
phthalate adduct. Probably it is noncovalently 
bound radioactivity from contaminating pro-
tcins or labeled metabolites which may not 
have been completely removed in this specific 
sample. Our negative finding is in accordance 
qualitatively with that of Albro et al. ( 1982) 
who also did not find any radioactivity in the 
DNA after oral administration of carboxylate-
labeled [14C]DEHP. Due to the fact that they 
administered only about 6.6 X 108 dpm/kg, 
i.e., about 20 times less than the dose used in 
our study, their finding is Iess valuable, how-
ever, on a quantitative basis for an exclusion 
of a genotoxic activity. 
When the Iabel was in the alcohol moiety 
(DEHP II and 111), radioa~tivity was easily 
detected in all samples, regardless of whether 
the Iabel was 14C or 3H. Apparent binding 
indices of 3 and 0.5 were obtained for the 14C 
and 3H Iabels, respectively, and pretreatment 
was without influence. After administration 
of (14C]EH IV, the radioactivity in the DNA 
was about twice the respective value obtained 
from (14C]DEHP ß administration and ap-
parent binding indices of about 6 resulted. 
The radioactivity associated with the DNA 
samples could be due to noncovalent inter-
action of the compound or some metabolite 
with DNA, to biosynthetic incorporation of 
radiolabeled precursors of DNA synthesis, or 
to true covalent adducts with DNA. Contam-
ination of the DNA with radiolabeled protein 
cannot contribute substantially to the DNA 
radioactivity because the specific activity of 
chromatin protein was only about 50 times 
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higher than that of DNA which is known to 
be contaminated by a maximum of0.2% pro-
tein (Sagelsdorff et al., 1983). 
The relatively high 14C02 production seen 
after administration of DEHP II and EH IV 
indicates that a large fraction of the alcohol 
moiety is degraded in the body. The degra-
dation products may then be used as precur-
sors in the biosynthesis of the deoxyribonu-
cleosides. After oral administration of 
[ 14C]methanol to rats, the 14C02 exhalation 
amounted to 80% of the dose. The radioac-
tivity in the liver DNA isolated 12 hr after 
the administration of P4C]methanol eorre-
sponded to a CBI of 170 (Däniken et al., 1981 ). 
The 14C02 exhaled after [14C]DEHP admin-
istrationwas 25-50 times smaller, in the range 
of 1.5-3% ofthe dose. A CBI in the region of 
3-6 may therefore easily be explained on the 
basis ofbiosynthetic incorporation. This find-
ing is in perfect agreement with the values 
around 3 as measured here (Table 1 ). 
The 3H radioactivity in the DNA measured 
after the administration of [3H]DEHP 111 was 
about 12 times lower than the 14C radioactivity 
originating from DEHP II. Again, this radio-
activity was shown to result primarily from 
biosynthetic incorporation into DNA of tri-
tiated breakdown products produced during 
the Oxidation ofthe Iabeted hexanol. Tritiated 
water was also shown to be formed and the 
specific activity of HTO in the 16-hr urine 
was about 2 X 107 dpm/ml. Control experi-
ments with oral administration of HTO and 
isolation of liver DNA after 24 hr revealed 
that radiolabel is associated with the DNA on 
an apparent CBI Ievel of 0.5 (Lutz, 1979). 
This radioactivity is not lost from the DNA 
upon washing so that it does not represent 
simple proton-tritium ion exchange. One 
possibility for the formation of a stable car-
bon-tritium bond is given for instance by the 
reduction of the 2'-hydroxyl group of the ri-
bonucleoside diphosphate to the 2'-deoxy de-
rivative of DNA. A quantitative comparison 
similar to the one calculated above with the 
14C Iabel is rendered more complicated, how-
ever, because the HTO formed in the liver 
cell from oxidative metabolism of DEHP 111 
reaches a higher intracellular concentration as 
compared with HTO distributed uniformly 
after oral administration. 
Although the above discussion clearly in-
dicates that 14C and 3H radioactivities in the 
DNA isolated after administration of alcohol-
labeled DEHP ß and 111 can be explained by 
reasons other than covalent interaction of re-
active metabolites, this hypothesisbad tobe 
corroborated on the basis of an analysis of 
DNA constituents. 
Analysis of nucleosides. An analysis of de-
oxyribonucleosides was carried out with the 
DNA obtained from rats treated with 14C- and 
3H-labeled DEHP II and ßl and 14C-labeled 
EH IV. The elution of the natural deoxyri-
bonucleosides localized by their optical density 
at 254 nm was the same for a1l DNA samples 
and is shown on the bottom of Figs. 6 and 7. 
Retention times of 8.5 min for deoxycytidine 
(dC), 11.5 min for deoxyguanosine (dG), 13.5 
min for thymidine (T}, and 18 min for de-
oxyadenosine (dA) were recorded. The peak 
appearing at 10.0 min represented deoxy-
inosine ( dl) which was formed in variable 
amounts during the hydrolysis of the DNA 
by enzymatic deamination of deoxyadenosine 
by enzyme impurities. 
Figure 6 shows the elution of the 14C and 
3H radioactivity of the digested DNA of an-
imals that had been given alcohol-labeled 
DEHP (II plus 111). lt can readily be seen that 
no radioactivity elutes after deoxyadenosine, 
i.e., in the region known to contain the 
more lipophilic deoxyribonucleoside-carcin-
ogen adducts, derived for example from benzo-
[a]pyrene (Jennette et a/., 1977; Boroujerdi et 
al., 1981 ), dimethylbenz[a]anthracene (Jeffrey 
et a/., 1976), or 3-methylcholanthrene (King 
et al., 1977). Radioactivity eluted exclusively 
with the front peak and with natural nucleo-
sides. The fractions containing the natural nu-
cleosides amounted to the largest part of the 
total radioactivity eluted, representing 87 to 
97% 14C and 42 to 69% 3H. If these radioac-
tivities, clearly due to biosynthetic incorpo-
ration of radiolabeled DEHP-breakdown 
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Fraction number 
B 
F'IG. 6. HPLC elution proffies of deoxyribonucleosides obtained from enzymatically degraded liver DNA. 
Four rats bad been orally administered DEHP (II plus 111), 14C- and 3H-labeled in the alcohol moiety, two 
with ( +) and two without (-) pretreatment with unlabeled DEHP. The · optical density profile (254 nm; 
bottom diagram) was identical for all four samples. The solid line indicates the Ievel of background radio-
activity; the dashed line shows the Iimit of detection of the radioactivity in the different chromatograms. 
(A) 1"C channel; (B) 3H channel. 
products, are deducted from the total apparent 
CBI as given in Table I, residual values ofO.l 
to 0.5 and 0.2 to 0.3 for 14C and 3H, respec-
tively, result. This view is the most conser-
vative approach based on the assumption that 
the front peak is due to some sort of DNA 
adduct fonned by the alcohol moiety of 
DEHP. 
These front fractions, No. 2 plus No. 3 of 
the deoxyribonucleoside chromatograms, 
contained 3-13 and 31-58% of the 14C and 
3H radioactivity, respectively. Such early elut-
ing radioactivity is generally observed in 
HPLC analyses ofDNA degradation products. 
It could be due to tightly but noncovalently 
bound DEHP metabolites, including tritiated 
water, released from the DNA only after 
breakdown to the nucleosides. It is also pos-
sible that it contains oligo-nucleotides formed 
by incomplete enzymatic degradation, or sug-
ars produced from degradation of apurinic 
acid. The latter DNA fragments could have 
their radioactivity from either biosynthetic in-
corooration or covalently bound test sub-
stance. 
The same Situation was observed with 
[ 14C]ethylhexanol IV (Fig. 7). After deduction 
of the biosynthetic incorpomtion of radiolabet 
(83 to 90% of the total specific activity), a 
maximum possible CBI of 0.6 to 0.9 could 
result. In this experiment all deoxyadenosine 
bad been converted to deoxyinosine. 
Another way of estimating maximum pos-
sible CBI could be based upon the general 
assumption that carcinogen-deoxyribonucle-
oside adducts are expected to elute only after 
20 min in the region of fractions 11-28, due 
to a higher lipophilicity of such adducts. No· 
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FIG. 7. HPLC elution profi.le of deoxyribonucleosides 
obtained from enzymatically degraded liver DNA. Two 
ratsbad been orally administered [1"C)EH IV, after pre-
treatment with unlabeled DEHP. The optical density pro-
file (254 nm; bottom diagram) was identical for the two 
samples. The solid line indicates the Ievel of background 
radioactivity; the dashed line shows the Iimit of detection 
of the radioactivity in the different chromatograms. 
radioactivity could be detected in this region. 
On the basis of the standard deviation of the 
background radioactivity ( dashed line in Figs. 
6 and 7), a Iimit of detection for a possible 
carcinogen-deoxyribonucleoside adduct can 
be given. The maximum CBI ofDEHP is then 
below 0.07 for [14C]DEHP II, below 0.04 for 
[lH]DEHP ßl, and below 0.03 for e4C]EH 
IV. This Iimit of detection is therefore almost 
as low as that of the carboxylate-labeled 
DEHP I. 
Analysis of purines. The above discussion 
is based upon the general knowledge that nu-
cleoside adducts of typical genotoxic carcin-
ogens such as benzo[a]pyrene, dimethylbenz 
[a]anthracene, or 3-methylcholanthrene elute 
after the natural nucleosides, due to increased 
lipophilicity. It is possible that smaller adducts 
such as methylated or ethylated nucleosides 
would not elute much later than the parent 
natural nucleoside. Therefore, a purine base 
analysiswas performed after acid hydrolysis 
of two DNA samples of two anirnals treated 
with DEHP II plus 111, one each with and 
without DEHP pretreatment. The HPLC sys-
tem chosen was known to separate 7 -methyl-
or 7-ethylguanine, the mostabundant alkyl-
ation products in DNA, from their parent 
base. The elution profile is shown in Fig. 8. 
No radioactivity was detectable at elution vol-
umes known for methylated or ethylated 
products and a Iimit of detection was CBI 
< 0.05 and <0.09 for [f 4C]DEHP II and CBI 
< 0.03 and <0.05 for [3H]DEHP III, with and 
without DEHP pretreatment, respectively. 
DNA-Binding Studies in the Mouse 
The data on the radioactivity determined 
in the mouse liver DNA are surnmarized in 
Table 2. With P4C]DEHA V and [3H]DEHA 
VI, DNA radioactivity was detectable in all 
(3H) DEHP ID {t) 
20 
i: w-~-w=~--~"""""l=t-:::=:::oo~ 
'i J 16 
14 -
16 
14 -
12 
5 10 15 20 25 
Frec:tlon number 
Fto. 8. HPLC elution profile of purine bases obtained 
from acid-hydrolyzed liver DNA. Rats bave been orally 
administered P"Cl- and (3H]DEHP (U plus ID), one with 
( +) and one without (-) pretreatment with unlabeled 
DEHP. The optical density proftle (254 nm; bottom dia-
gram) was identical for the two samples. The solid line 
indicates the Ievel ofbackground radioactivity; the dashed 
line shows the limit of detection of the radioactivity in 
the different chromatograms. 
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samples. Upon comparison of individual val-
ues, the 3H value of one nonpretreated animal 
was almost ten times higher than that of the 
other. lt is likely that this vial contained traces 
of 3H radioactivity not due to the DNA sample 
because the 14C Ievels were similar, and the 
14C to 3H ratio of a1l other DNA samples was 
between 3 and 5 whereas that specific DNA 
sample showed a ratio of 0.5. By not taking 
into consideration this probably contaminated 
tritium value, apparent binding indices in CBI 
units of 0.05-0.15 and 0.01-0.03 resulted for 
the 14C and 3H label, respectively. 
Although radioactivity in the DNA was de-
tectable in all experiments, the specific activ .. 
ities were minute (<50 dpm/mg DNA for 3H 
and <38 dpmjmg for 14C) after administration 
of extremely large doses of radioactivity (>5 
X 1011 and >7 X 1010 dpm/kg body wt, re ... 
spectively). It was therefore useless todegrade 
the DNA to nucleosides or bases because the 
HPLC analysis would not have allowed the 
determination of the fraction of radioactivity 
which was incorporated into DNA via bio-
synthesis. The only possibility for a quanti-
tative estimation ofthat source ofradioactivity 
was by measuring the formation of 14C02 and 
HTO. The C02 data compiled in Fig. 5 show 
that the DNA radioactivities were proportional 
to the initial rate of expiration of 14C Iabel. 
This finding is a good indication that biosyn-
thetic incorporation of radiolabeled break-
down products was the main reason for the 
DNA labeling. 
The experiment with alcohol-labeled 
[14C]DEHP II in the mousewas performed 
to establish a link to the results obtained with 
rats. There, the radioactivity in the liver DNA 
expressed in CBI units was about 3 as opposed 
to the mean value of0.05 for mouse (Tables 
1 and 2). The difference by a factor of about 
60 is due first to a species difference of about 
one order of magnitude for biosynthetic in-
corporation of 14C02 into Ii ver DNA as found 
earlier in control experiments with oral ad-
ministration of [14C]methanol to mice and rats 
(data not shown), and second, to the fact that 
the production of 14C02 was about twice as 
high in the rat. The speciftc activity of the 
liver DNA isolated from the rats was high 
enough to allow proof that the natural de-
oxyribonucleosides were radiolabeled (Fig. 6). 
The DNA radioactivity measurable on the 
liver DNA of mice treated with [14C]DEHP 
II is therefore most likely also due to biosyn-
thetic incorporation of radiolabeled break-
down products into DNA. The same argument 
holds for the results obtained after adminis-
tration of [l 4C]EH IV. 
The tritium radioactivity in the DNA mea-
sured after the administration of [3H]DEHA 
VI was three to five times lower than the 14C 
radioactivity originating from DEHA V if the 
specific activities are normalized to the dose 
administered by using CBI units. Again, the 
tritium radioactivity could result from bio-
synthetic incorporation into DNA oftritiated 
breakdown products, produced during the Ox-
idation of the labeled hexanol. Tritiated water · 
was shown to be formed and the specific ac-
tivity of HTO in urine was between l and 4 
X 10 7 dpmjml. This Ievel could be achieved 
from an oxidation and release of 1 to 4% of 
the 3H activity administered. This fraction is 
in good agreement with the fraction of the 
14C radioactivity expired in the. form of co2. 
Control experiments with oral administration 
of HTO to mice and isolation of Ii ver DNA 
after 24 hr revealed that radiolabet is indeed 
incorporated in the natural deoxyribonucle-
osides on an apparent CBI of 0.05 (Sagelsdorff, 
1982). A quantitative comparison sirnilar to 
the one performed above with the 14C Iabel 
is rendered more complicated, however, be-
cause the HTO formed in the liver cell from 
oxidative metabolism of DEHA II will reach 
a higher intracellular concentration compared 
to HTO distributed uniformly after oral ad-
ministration. 
lf all the evidence presented above is taken 
into account, there is little doubt that negligible 
or none of the DNA radioactivity detected 
after administration of { 14C]- and PH]DEHA 
can be due to covalent interactions. Any true 
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covalent binding of DEHA to mouse liver 
DNA will therefore be below CBI < 0.0 1. 
DISCUSSION . 
Our data do not give any indication for a 
covalent binding ofDEHP and DEHA to liver 
DNA of rats and mice, respectively. Nucleo-
side and base analyses as well as correlations 
obtained between 14C02 expired and specific 
activity of DNA, in both rats and mice, al-
lowed us to conclude that the radioactivity 
associated with the DNA was largely due to 
biosynthetic incorporation of radiolabeled 
breakdown products. [ 14C]EH administration 
gave rise to the highest DNA radioactivities 
and to the highest Ievel of 14C02 exhalation. 
This result is in contrast to the data reported 
by Albro et a/. ( 1982), where only RNA but 
not DNA was found to be radiolabeled after 
administration of [ 14C]EH. Although the 
amount of radioactivity administered was 
much smaller than in our experiments, it 
should have been possible to measure radio-
activity in the DNA because Albro et a/. ( 1982) 
did detect radioactivity in the DNA after a 
similar radioactive dose of [14C]DEHP II. 
Furthermore, in an additional experiment 
with mono(2-ethyl[l-14C]hexyl) phthalate, 
they did measure radioactivity in both types 
of nucleic acids and the radioactivity in RNA 
was very similar to the value measured after 
administration of [14C]EH. This contrast is 
not readily explained since both nucleic acids 
contain the same nucleophilic centers, and 
the biosynthetic incorporation into RNA is 
unlikely to change so drastically from one ex-
periment to another. We canoot explain their 
findings. 
The subsequent report published by this 
group (Albro et a/., 1983) does not provide 
any clue to solve the above controversy, but 
their new findings with alcohol-dual-labeled 
DEHP at least allowed the conclusion that the 
intact 2-ethylhexanol side chain cannot simply 
be attached to DNA. They showed, in addi-
tion, that urea isolated from the urine was 
14C-labeled, suggesting that the DNA could 
have been radiolabeled via biosynthesis. 
Jnfluence of the Pretreatment 
The specific activity of DNA, most if not 
all due to biosynthetic incorporation of ra-
diolabeled breakdown products, was not af-
fected by DEHP pretreatment of the rats or 
by DEHA pretreatment oftbe mice for 4 weeks 
with 1% in the diet .. The liver weight, on the 
other band, was increased after pretreatment. 
This finding means that DNA synthesis per 
unit Ii ver weight was no Ionger stimulated after 
4 weeks but seemed to be in stationary phase 
no different from controls. 
The fraction of the radioactivity dose ex-
haled in the form of 14C02 was larger after 
pretreatment by factors of 1.4 (DEHP I), 2.1 
(DEHP II), and 1.5 (DEHA V). The Ii ver was 
enlarged by factors of 1.5 (DEHP I) and 1.4 
(DEHP II) in the rat and 1.3 (DEHA V) in 
the mouse. The metabolic activity per unit 
liver weight therefore did not increase at all 
or only to a very small extent. DEHP therefore 
seems not tobe an effective inducer of its own 
metabolism. This finding confirms indirectly 
other data which show that peroxisomes can 
be induced without a marked effect on some 
cytochrome P-450-dependent activities (Wal-
seth et al., 1982). 
The Cova/ent Binding Index 
The expression of a DNA binding nor-
malized by the dose in the units ofthe covalent 
binding index, CBI, was introduced in 1977 
(Lutz and Schlatter, 1977a) for a comparison 
of the DNA-binding activities of various 
chemieals tested in a nurober of laboratories 
under widely different conditions. The values 
measured so far span about five orders of 
magnitude, ranging from more than 104 [af-
latoxin 8 1 (Lutz et a/., 1980)] down to about 
one [e.g. benzene (Lutz and Schlatter, 1977b)]. 
CBis have been shown to reflect very roughly 
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the genotoxic potency of a chemical. CBis of 
the order of 103 to 104 are found with potent 
carcinogens, of around 1 ()2 for moderate car-
cinogens, and of 1 to 10 for weak carcinogens 
with a genotoxic mode of action. A plot of 
the CBI in the target organ as a function of 
the respective tumorigenic potency in TD50 
units derived from long-term bioassays on 
carcinogenicity has been set up with 13 chem-
ieals for which both values were published 
(Lutz, 1982a). The surprisingly high correla-
tion coefficient of0.74 calculated from a linear 
regression analysis therefore seems to allow 
placement of a test compound into a category 
according to the importance of DNA binding 
as one factor contributing to the overall tu-
morigenicity. 
Our results allow the conclusion that the 
liver DNA-binding ability of DEHP in rats 
and of DEHA in mice must be well below a 
value of 0.05, expressed in CBI units. This is 
almost one million times below the genotox-
icity of aflatoxin B1, where daily doses of as 
little as 1 o-s mmol/kg resulted in detectable 
tumor formation. If the much lower maxi-
mum possible DNA binding by DEHP and 
DEHA should become responsible for a pos-
itive result in a rodent bioassay on. carcino-
genicity, impossibly high doses or an unreal-
istically large number of animals would be 
required if the correlation of carcinogenic po-
tency to DNA binding is extrapolated to a 
CBI value of 0.05 (Lutz, l982a). 
The fact that a tumorigenicity of DEHP 
and DEHA has clearly been demonstrated, 
however, is an indication that activities other 
than DNA binding ofthe test compound must 
be responsible. The observation that induction 
of peroxisomes is associated with increased 
hepatic tumor formation (Reddy et a/., 1980) 
and the finding of an excessive accumulation 
of autofluorescent lipofuscin in the Ii ver during 
bepatocarcinogenesis by peroxisome prolif-
erators (Reddy et al .• 1982) led these authors 
to the bypothesis that persistent proliferation 
of peroxisomes and increase in peroxisomal 
ß-oxidation systems could serve as an endog-
enous initiator of the neoplastic transforma-
tion ofliver cells by increasing the intracellular 
production ofDNA-damaging H202 and other 
reactive oxygen intermediates. 
A DNA-binding assay in vivo finds an im-
portant application where a long-term assay 
on carcinogenicity was clearly positive, but 
where additional infonnation, such as mu-
tagenicity data, renders a genotoxic mode of 
action via DNA binding unlikely (Lutz, 
1982b). These requirements are met with 
DEHP and DEHA. Here, it was important to 
verify the Iack of DNA binding of the com-
pound also in a mammalian organism. Neg-
ative results as shown above suggest that the 
tumorigenicity might have been dependent on 
the onset of some type of biological response 
which should also have been observable in the 
bioassay. With DEHP and DEHA, this re-
sponse could well be the proliferation of per-
oxisomes. For an assessment of the risk for 
man from exposure to this type of carcinogen, 
it will therefore be important to establish dose-
effect relationships and to further substantiate 
the importance of species differences. 
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